Macrophage
Immune-Oncology Assays
- ADCP
- MDSC
- M1/M2
- TAM
- Efferocytosis
- Phagocytosis
- Cytokine Release Assay (CRA)-predictive toxicity
Inflammation Assays
- M1/M2 polarisation and function
- Cytokine Release Assay (CRA)-predictive toxicity
A THP-1 macrophage cytokine release assay can be used to explore modulators of an inflammatory response or “de-risk” any potential unwanted effects of novel therapeutic delivery systems
THP-1 Macrophage cell line Cytokine Release
THP-1 cells were differentiated with PMA and then stimulated with LPS to induce cytokine release in the presence of different concentrations of the corticosteroid dexamethasone. Cytokine release was measured at 4h and 24h post LPS stimulation.
THP-1 macrophage cell line phagocytosis and efferocytosis
THP-1 macrophage phagocytosis of E.Coli bioparticles and efferocytosis of Heat Shock treated A-375 melanoma tumour cells. THP-1 cells were cultured with E.Coli bioparticles 0-12.5ug/ml; at 1h phagocytosis was evaluated by pHrodo+ cells using flow cytometry. THP-1 cells were cultured with three E:T ratios of A-375 or heat shock treated A-375; at 1h efferocytosis was evaluated by pHrodo+ cells using flow cytometry.
Drug Discovery Tool
Find the right immune assay for your therapeutic area, modality and target using this interactive Drug Discovery Tool.